Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Landscape of immunoglobulin heavy chain γ gene class switch recombination in patients with adult T-cell leukemia-lymphoma.
Hiramatsu H, Nosaka K, Kusumoto S, Nakano N, Choi I, Yoshimitsu M, Imaizumi Y, Hidaka M, Sasaki H, Makiyama J, Ohtsuka E, Jo T, Ogata M, Ito A, Yonekura K, Tatetsu H, Kato T, Kawakita T, Suehiro Y, Ishitsuka K, Iida S, Matsutani T, Nishikawa H, Utsunomiya A, Ueda R, Ishida T. Hiramatsu H, et al. Haematologica. 2023 Apr 1;108(4):1173-1178. doi: 10.3324/haematol.2022.281435. Haematologica. 2023. PMID: 36420800 Free PMC article. No abstract available.
Clinical landscape of TP73 structural variants in ATL patients.
Hiramatsu H, Yokomori R, Shengyi L, Tanaka N, Mori S, Kiyotani K, Gotoh O, Kusumoto S, Nakano N, Suehiro Y, Ito A, Choi I, Ohtsuka E, Hidaka M, Nosaka K, Yoshimitsu M, Imaizumi Y, Iida S, Utsunomiya A, Noda T, Nishikawa H, Ueda R, Sanda T, Ishida T. Hiramatsu H, et al. Leukemia. 2023 Dec;37(12):2502-2506. doi: 10.1038/s41375-023-02059-9. Epub 2023 Oct 20. Leukemia. 2023. PMID: 37864123 Free PMC article. No abstract available.
Long-term efficacy and safety of perampanel monotherapy in patients with newly diagnosed or currently untreated recurrent focal-onset seizures: Results from the open-label extension phase of FREEDOM (Study 342).
Yamamoto T, Lim SC, Ninomiya H, Kubota Y, Shin WC, Kim DW, Shin DJ, Iida K, Ochiai T, Matsunaga R, Hiramatsu H, Kim JH. Yamamoto T, et al. Among authors: hiramatsu h. Epilepsy Res. 2024 Dec 20;210:107494. doi: 10.1016/j.eplepsyres.2024.107494. Online ahead of print. Epilepsy Res. 2024. PMID: 39788068 Free article.
Theoretical and data-driven approaches to semiconductors and dielectrics: from prediction to experiment.
Oba F, Nagai T, Katsube R, Mochizuki Y, Tsuji M, Deffrennes G, Hanzawa K, Nakano A, Takahashi A, Terayama K, Tamura R, Hiramatsu H, Nose Y, Taniguchi H. Oba F, et al. Among authors: hiramatsu h. Sci Technol Adv Mater. 2024 Nov 4;25(1):2423600. doi: 10.1080/14686996.2024.2423600. eCollection 2024. Sci Technol Adv Mater. 2024. PMID: 39687423 Free PMC article. Review.
Real-world Outcomes of Commercial Tisagenlecleucel for Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia in Japan.
Kato I, Tomizawa D, Kato M, Hirabayashi S, Manabe A, Irie M, Sasahara Y, Arakawa Y, Koh K, Sakaguchi H, Sugiyama M, Ogawa C, Kamiya T, Saito S, Nakazawa Y, Nishio N, Takahashi Y, Iwai N, Adachi S, Takita J, Miyamura T, Yokoyama S, Oba U, Ueda T, Koga Y, Hiramatsu H. Kato I, et al. Among authors: hiramatsu h. Transplant Cell Ther. 2024 Nov 30:S2666-6367(24)00799-1. doi: 10.1016/j.jtct.2024.11.016. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39617098 Free article.
Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.
Kato S, Tsujimoto SI, Matsubayashi J, Iwamoto S, Hiramatsu H, Okuno Y, Kamitori T, Ohki K, Deguchi T, Kiyokawa N, Kato M, Takita J, Tanaka S, Adachi S, Tomizawa D, Shiba N. Kato S, et al. Among authors: hiramatsu h. Haematologica. 2025 Jan 1;110(1):251-256. doi: 10.3324/haematol.2024.286243. Haematologica. 2025. PMID: 39234860 Free PMC article. No abstract available.
MGMT protein expression is a reliable predictive biomarker for temozolomide-containing chemotherapy in osteosarcoma.
Uchihara Y, Umeda K, Yamada Y, Ito H, Tasaka K, Isobe K, Akazawa R, Kawabata N, Saida S, Kato I, Hiramatsu H, Noguchi T, Sakamoto A, Arakawa Y, Arakawa A, Yamamoto N, Hosoya Y, Uemura S, Watanabe KI, Sano H, Taga T, Takita J. Uchihara Y, et al. Among authors: hiramatsu h. Cancer Sci. 2024 Oct;115(10):3394-3402. doi: 10.1111/cas.16297. Epub 2024 Jul 30. Cancer Sci. 2024. PMID: 39080996 Free PMC article.
Quadrupling the depairing current density in the iron-based superconductor SmFeAsO1-xHx.
Miura M, Eley S, Iida K, Hanzawa K, Matsumoto J, Hiramatsu H, Ogimoto Y, Suzuki T, Kobayashi T, Ozaki T, Kurokawa H, Sekiya N, Yoshida R, Kato T, Okada T, Okazaki H, Yamaki T, Hänisch J, Awaji S, Maeda A, Maiorov B, Hosono H. Miura M, et al. Among authors: hiramatsu h. Nat Mater. 2024 Oct;23(10):1370-1378. doi: 10.1038/s41563-024-01952-7. Epub 2024 Jul 18. Nat Mater. 2024. PMID: 39026087 Free PMC article.
429 results